Tivic Health Systems, Inc. (TIVC) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Valion Bio, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.738 and the questions you have submitted in advance will be answered following the prepared 00:00:04.738 -- 00:00:10.286 remarks. This call is being webcast, and the replay will be available on the IR section 00:00:10.286 -- 00:00:13.070 of the company's website for three months. 00:00:13.070 -- 00:00:18.117 Before we begin, let me remind you that during today's call, management will make various 00:00:18.117 -- 00:00:22.663 forward-looking statements. Investors are questioned that these forward-looking statements 00:00:22.663 -- 00:00:25.127 are based on current expectations 00:00:25.127 -- 00:00:27.638 and are subject to risks and uncertainties. 00:00:27.638 -- 00:00:32.823 That could cause actual results or outcomes to differ materially from those indicated 00:00:32.823 -- 00:00:37.588 in our forward-looking statements. Please read the safe harbor statement contained in 00:00:37.588 -- 00:00:43.173 the press release, Terrific Health issued today, as well as the risk factors contained 00:00:43.173 -- 00:00:48.338 in Terrific Health's filings with the SEC, including its annual report 00:00:48.338 -- 00:00:53.563 on Form 10-K of the year end December 31, 2024, and the Form 10-Q 00:00:53.563 -- 00:00:55.060 report 00:00:55.060 -- 00:01:00.790 to be filed with the SEC today, as well as other companies' SEC filings. 00:01:00.790 -- 00:01:06.661 On today's call, we have Trivik Health's Chief Executive Officer, Jennifer Earnest, 00:01:06.661 -- 00:01:11.670 Interim Chief Financial Officer, Lisa Wolf, and Chief Operating Officer and 00:01:11.670 -- 00:01:14.455 President of Trivik Biopharma, 00:01:14.455 -- 00:01:20.502 Michael Hanley. Now let me turn the call over to Jennifer Earnest. 00:01:23.883 -- 00:01:28.169 Thank you to the operator f...